Literature DB >> 20075153

Role of c-Jun N-terminal kinase in the regulation of vascular tone.

Ming-Sheng Zhou1, Ivonne Hernandez Schulman, Kiranmai Chadipiralla, Leopoldo Raij.   

Abstract

The c-Jun N-terminal kinases (JNKs) belong to the mitogen-activated protein kinases superfamily, which play an important role in the pathogenesis of cardiovascular and metabolic diseases. However, it is still unclear whether JNK participates in the regulation of vascular tone. We investigated the effect of JNK inhibitors on vascular reactivity in aortic rings in organ bath and on angiotensin (Ang) II-induced pressor responses in vivo in Sprague-Dawley (SD) rats. In aortic rings from SD rats, KCl, norepinephrine (NE), Ang II, or endothelin 1 (ET)-1 induced a dose-dependent vasoconstriction. Preincubation with the JNK inhibitor SP600125 (20 micromol/L) slightly inhibited KCl-induced vasoconstriction (Emax: -19%) and markedly inhibited vasoconstriction to NE (-42%), Ang II (-54%), and ET-1 (-42%). SP600125 induced a dose-dependent relaxation in the NE-preconstricted aortic rings (-54%) but exerted minimal relaxation in the KCI-preconstriction rings. To exclude the nonspecific effect of SP600125, we performed additional experiments using JNK peptide inhibitor 1, L-stereoisomer (L-JNKI1), a cell-permeable peptide inhibitor specific for JNK. Compared to SP600125, L-JNKI1 (20 micromol/L) had a smaller but still significant inhibitory effect on NE-induced vasoconstriction (-18%) and did not inhibit KCI-induced vasoconstriction. Next, we investigated the effect of L-JNKI1 (5 mg/kg intravenously [IV]) in vivo on Ang II-induced pressor responses in SD rats. Ang II induces a dose-dependent increase in systolic blood pressure and L-JNKI1 slightly attenuated the Ang II-induced pressor response. These results suggest that JNK signaling plays a role in the regulation of vascular tone.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20075153     DOI: 10.1177/1074248409354603

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol Ther        ISSN: 1074-2484            Impact factor:   2.457


  9 in total

1.  Clinical correlates of serum pigment epithelium-derived factor in type 2 diabetes patients.

Authors:  Alicia J Jenkins; Dongxu Fu; Madona Azar; Julie A Stoner; Derrick G Kaufman; Sarah Zhang; Richard L Klein; Maria F Lopes-Virella; Jian-Xing Ma; Timothy J Lyons
Journal:  J Diabetes Complications       Date:  2014-01-17       Impact factor: 2.852

2.  Inhibition of adrenergic human prostate smooth muscle contraction by the inhibitors of c-Jun N-terminal kinase, SP600125 and BI-78D3.

Authors:  F Strittmatter; S Walther; C Gratzke; J Göttinger; C Beckmann; A Roosen; B Schlenker; P Hedlund; K E Andersson; C G Stief; M Hennenberg
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

3.  Upregulation of Sestrin2 expression protects against macrophage apoptosis induced by oxidized low-density lipoprotein.

Authors:  Hong-Juan Hu; Ze-Ya Shi; Xiao-Lin Lin; San-Mei Chen; Qing-Yan Wang; Si-Yuan Tang
Journal:  DNA Cell Biol       Date:  2015-02-18       Impact factor: 3.311

4.  Endothelin-1 impairs coronary arteriolar dilation: Role of p38 kinase-mediated superoxide production from NADPH oxidase.

Authors:  Naris Thengchaisri; Travis W Hein; Yi Ren; Lih Kuo
Journal:  J Mol Cell Cardiol       Date:  2015-07-23       Impact factor: 5.000

Review 5.  Toll-like receptors and damage-associated molecular patterns: novel links between inflammation and hypertension.

Authors:  Cameron G McCarthy; Styliani Goulopoulou; Camilla F Wenceslau; Kathryn Spitler; Takayuki Matsumoto; R Clinton Webb
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-10-25       Impact factor: 4.733

6.  Inhibition of Vascular c-Jun N-Terminal Kinase 2 Improves Obesity-Induced Endothelial Dysfunction After Roux-en-Y Gastric Bypass.

Authors:  Petia Doytcheva; Thomas Bächler; Erika Tarasco; Vincenzo Marzolla; Michael Engeli; Giovanni Pellegrini; Simona Stivala; Lucia Rohrer; Francesco Tona; Giovanni G Camici; Paul M Vanhoutte; Christian M Matter; Thomas A Lutz; Thomas F Lüscher; Elena Osto
Journal:  J Am Heart Assoc       Date:  2017-11-14       Impact factor: 5.501

7.  Involvement of AP-1 and C/EBPβ in upregulation of endothelin B (ETB) receptor expression in a rodent model of glaucoma.

Authors:  Shaoqing He; Alena Z Minton; Hai-Ying Ma; Dorota L Stankowska; Xiangle Sun; Raghu R Krishnamoorthy
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

8.  Upregulation of ERK1/2-eNOS via AT2 receptors decreases the contractile response to angiotensin II in resistance mesenteric arteries from obese rats.

Authors:  Graziela N Hagihara; Nubia S Lobato; Fernando P Filgueira; Eliana H Akamine; Danielle S Aragão; Dulce E Casarini; Maria Helena C Carvalho; Zuleica B Fortes
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240

9.  Upregulation of sestrin-2 expression protects against endothelial toxicity of angiotensin II.

Authors:  Lao Yi; Feng Li; Yuan Yong; Dong Jianting; Zhang Liting; Huang Xuansheng; Li Fei; Li Jiewen
Journal:  Cell Biol Toxicol       Date:  2014-05-18       Impact factor: 6.691

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.